Utility of Rivaroxaban for Real-World Patients With Venous Thromboembolism

被引：0
|
作者：
Yamashita, Yugo [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, 54 Shogoin Kawahara Cho, Sakyo Ku, Kyoto 6068507, Japan
来源：
CIRCULATION JOURNAL | 2023年 / 87卷 / 09期
关键词：
ORAL RIVAROXABAN;
D O I：
10.1253/circj.CJ-23-0291
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1185 / 1186
页数：2
相关论文
共 50 条
  • [21] Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States
    Jeffrey S. Berger
    François Laliberté
    Akshay Kharat
    Dominique Lejeune
    Kenneth Todd Moore
    Young Jung
    Patrick Lefebvre
    Veronica Ashton
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 438 - 448
  • [22] Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
    Lu, Kepeng
    Liao, Qian-Qian
    Zhu, Ke-Wei
    Yao, Ying
    Cui, Xiao-Jiao
    Chen, Peng
    Bi, Ying
    Zhong, Meng
    Zhang, Hao
    Tang, Jing-Cai
    Yu, Qin
    Yue, Jia-Kui
    He, Hui
    Zhu, Ze-Feng
    Cai, Ze-Zheng
    Yang, Zhe
    Zhang, Wei
    Dong, Yang-Tao
    Wei, Qiu-Mian
    He, Xuegai
    ADVANCES IN THERAPY, 2024, 41 (01) : 451 - 463
  • [23] Efficacy and Safety of Different Doses of Rivaroxaban and Risk Factors for Bleeding in Elderly Patients with Venous Thromboembolism: A Real-World, Multicenter, Observational, Cohort Study
    Kepeng Lu
    Qian-Qian Liao
    Ke-Wei Zhu
    Ying Yao
    Xiao-Jiao Cui
    Peng Chen
    Ying Bi
    Meng Zhong
    Hao Zhang
    Jing-Cai Tang
    Qin Yu
    Jia-Kui Yue
    Hui He
    Ze-Feng Zhu
    Ze-Zheng Cai
    Zhe Yang
    Wei Zhang
    Yang-Tao Dong
    Qiu-Mian Wei
    Xuegai He
    Advances in Therapy, 2024, 41 : 391 - 412
  • [24] Effectiveness, safety, and healthcare costs associated with rivaroxaban versus warfarin among venous thromboembolism patients with obesity: a real-world study in the United States
    Berger, Jeffrey S.
    Laliberte, Francois
    Kharat, Akshay
    Lejeune, Dominique
    Moore, Kenneth Todd
    Jung, Young
    Lefebvre, Patrick
    Ashton, Veronica
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (03) : 438 - 448
  • [25] Real-world data: incidence of venous thromboembolism recurrence and bleeding among cancer patients
    Silva-Cardenas, D. C.
    Pikabea-Diaz, F.
    Zumarraga-Cuesta, A.
    Lopez-Santillan, M.
    Figaredo-Berjano, C.
    Loaiza-Jaramillo, P. L.
    Casado-Cuesta, P.
    Temino-Frances, M.
    Lopez-de-San-Vicente-Hernandez, B.
    Novo-Sukia, E.
    Legaspi-Folgueira, J.
    Barcelo-Galindez, J. R.
    Sande-Sardina, L.
    Nuno-Escolastico, M.
    Abad-Villar, M. T.
    Sala-Gonzalez, M. A.
    Galve-Calvo, E.
    Martinez-del-Prado, M. P.
    THROMBOSIS RESEARCH, 2022, 213 : S17 - S17
  • [26] Real-World Analysis of Venous Thromboembolism Rates and Thromboprophylaxis Prescribing In US Patients with Cancer
    Amin, Alpesh N.
    Lin, Jay
    Thompson, Stephen
    Wiederkehr, Daniel
    BLOOD, 2010, 116 (21) : 1555 - 1555
  • [27] Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes
    Hasan, Syed Shahzad
    Sunter, Wendy
    Ahmed, Nadia
    Dawoud, Dalia
    Zaidi, Syed Tabish Razi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (03) : 621 - 628
  • [28] Venous thromboembolism prophylaxis in patients undergoing knee replacements: comparison of real-world outcomes
    Syed Shahzad Hasan
    Wendy Sunter
    Nadia Ahmed
    Dalia Dawoud
    Syed Tabish Razi Zaidi
    International Journal of Clinical Pharmacy, 2021, 43 : 621 - 628
  • [29] Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients
    Matthew Williams
    Tania Ahuja
    Veronica Raco
    John Papadopoulos
    David Green
    Eugene Yuriditsky
    Serena Arnouk
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 219 - 229
  • [30] Real world prescribing practices of apixaban or rivaroxaban lead-in doses for the treatment of venous thromboembolism in hospitalized patients
    Williams, Matthew
    Ahuja, Tania
    Raco, Veronica
    Papadopoulos, John
    Green, David
    Yuriditsky, Eugene
    Arnouk, Serena
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2022, 54 (02) : 219 - 229
12345